PREDICTing Post-Embolization Syndrome after uterine fibroid embolization: the PREDICT-PES study.

ABSTRACT:

Objectives

To identify the rate of clinically significant post-embolization syndrome (csPES) in our cohort of patients after uterine artery embolization (UAE) for symptomatic fibroids and to identify risk factors associated with the development of csPES.

Methods

Retrospective case-control study. All patients who underwent UAE for symptomatic fibroids between the 18-month period of March 1, 2022 and September 1, 2023 were recruited. csPES was defined as maximum pain score on visual analogue scale of >5 out of 10, plus at least 1 of: morphine patient-controlled analgesia dose >10 mg, fever, or use of 2 or more antiemetics.

Results

A total of 69 patients were included, mean age 46.2 years, and median uterine volume 393 mL (range 80-2288 mL). The rate of csPES was 47.8% (

SUBMITTER: Clements W 

PROVIDER: S-EPMC12012349 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature